Oral Presentation — Publications

Resources and insights tagged oral presentation from Pedestal Health.

Publications

Saint Louis University UNC VCU Foundation for Liver Research / King's College Hospital / University of Birmingham

Use of glucagon-like peptide 1 receptor agonists in patients with MASLD in a real-world setting is associated with slower disease progression and lower all-cause mortality

Novartis AG Harvard Medical School / Beth Israel Deaconess AbbVie Inc.University of Alabama Birmingham

Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA

Use of advanced systemic therapy in adolescent patients with moderate to severe atopic dermatitis in the TARGET DERM Registry

Use of advanced systemic therapy in adolescent patients with moderate to severe atopic dermatitis in the TARGET DERM Registry (Hawaii Derm)

Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-fracture Treatment Among Commercially Insured Postmenopausal Women in the United States

Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-Fracture Treatment Among Commercially Insured Postmenopausal Women in the United States (ACR)

Non-alcoholic Steatohepatitis Disease Progression in Participants from the United States TARGET-NASH Real World Longitudinal Observational Study

Total Publications

Oral Presentation

2024 · Oral Presentation · Saint Louis University · Hepatology

Use of glucagon-like peptide 1 receptor agonists in patients with MASLD in a real-world setting is associated with slower disease progression and lower all-cause mortality

2024 · Oral Presentation · Novartis AG · Dermatology

Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA

2023 · Oral Presentation · Dermatology

Use of advanced systemic therapy in adolescent patients with moderate to severe atopic dermatitis in the TARGET DERM Registry

2023 · Oral Presentation · Methods/Pharmacoepi

Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-fracture Treatment Among Commercially Insured Postmenopausal Women in the United States

2023 · Oral Presentation · Hepatology

Non-alcoholic Steatohepatitis Disease Progression in Participants from the United States TARGET-NASH Real World Longitudinal Observational Study

2023 · Oral Presentation · Harvard T.H. Chan School of Public Health · Methods/Pharmacoepi

HIV risk perception and PrEP adherence among South African women planning for pregnancy and participating in STI screening

2023 · Oral Presentation · Dermatology

Unmet Needs of Adolescents with Moderate to Severe Atopic Dermatitis in the TARGET-DERM Registry

2022 · Oral Presentation · Botswana Ministry of Health and Wellness · Methods/Pharmacoepi

HIV Incidence in Botswana Rural Communities With High Antiretroviral Treatment Coverage: Results From the Botswana Combination Prevention Project, 2013-2017

2022 · Oral Presentation · Brigham and Women's Hospital · Methods/Pharmacoepi

Health Impact and Cost-Effectiveness of HIV Testing, Linkage, and Early Antiretroviral Treatment in the Botswana Combination Prevention Project

2022 · Oral Presentation · Hepatology

Pruritus in Primary Biliary Cholangitis is Under-Treated in Clinical Practice: Results from TARGET-PBC (APASL)

2022 · Oral Presentation · Hepatology

The Pervasive Impact of Pruritus on Quality of Life in Patients with Primary Biliary Cholangitis (PBC): Real World Experience in TARGET-PBC (APASL)

2021 · Oral Presentation · University of Alabama at Birmingham · Methods/Pharmacoepi

Lipids testing trends before and after hospitalization for myocardial infarction among adults in the United States, 2008-2019

2020 · Oral Presentation · Hepatology

Clinical Profile of Nonalcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Mellitus

2020 · Oral Presentation · Gastroenterology

Objective Disease Activity Assessment and Therapeutic Drug Monitoring is Lacking Prior to Biologic Therapy Changes in Routine Inflammatory Bowel Disease Clinical Practice: TARGET-IBD

2020 · Oral Presentation · Hepatology

Weight Loss and Change in Alanine Aminotransferase (ALT) Among Patients with Nonalcoholic Fatty Liver Disease (NAFLD) Receiving Standard Care in Real World Clinical Practice: TARGET-NASH

2019 · Oral Presentation · Hepatology

Incidence of Achieving Weight Loss Goals in Usual Clinical Practice: Results for the TARGET-NASH Observational Cohort

2019 · Oral Presentation · University of Alabama at Birmingham · Methods/Pharmacoepi

Lipid testing trends in the US before and after the release of the 2013 ACC/AHA cholesterol guidelines

2018 · Oral Presentation · Amgen Inc. · Methods/Pharmacoepi

Real-world patterns of romiplostim treatment in adults with primary immune thrombocytopenia in the United States

2017 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi

Oral Presentation — Publications

Publications

Use of glucagon-like peptide 1 receptor agonists in patients with MASLD in a real-world setting is associated with slower disease progression and lower all-cause mortality

Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA

Use of advanced systemic therapy in adolescent patients with moderate to severe atopic dermatitis in the TARGET DERM Registry

Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-fracture Treatment Among Commercially Insured Postmenopausal Women in the United States

Non-alcoholic Steatohepatitis Disease Progression in Participants from the United States TARGET-NASH Real World Longitudinal Observational Study

Use of glucagon-like peptide 1 receptor agonists in patients with MASLD in a real-world setting is associated with slower disease progression and lower all-cause mortality

Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA

Use of advanced systemic therapy in adolescent patients with moderate to severe atopic dermatitis in the TARGET DERM Registry

Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-fracture Treatment Among Commercially Insured Postmenopausal Women in the United States

Non-alcoholic Steatohepatitis Disease Progression in Participants from the United States TARGET-NASH Real World Longitudinal Observational Study

HIV risk perception and PrEP adherence among South African women planning for pregnancy and participating in STI screening

Unmet Needs of Adolescents with Moderate to Severe Atopic Dermatitis in the TARGET-DERM Registry

HIV Incidence in Botswana Rural Communities With High Antiretroviral Treatment Coverage: Results From the Botswana Combination Prevention Project, 2013-2017

Health Impact and Cost-Effectiveness of HIV Testing, Linkage, and Early Antiretroviral Treatment in the Botswana Combination Prevention Project

Pruritus in Primary Biliary Cholangitis is Under-Treated in Clinical Practice: Results from TARGET-PBC (APASL)

The Pervasive Impact of Pruritus on Quality of Life in Patients with Primary Biliary Cholangitis (PBC): Real World Experience in TARGET-PBC (APASL)

Lipids testing trends before and after hospitalization for myocardial infarction among adults in the United States, 2008-2019

Clinical Profile of Nonalcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Mellitus

Objective Disease Activity Assessment and Therapeutic Drug Monitoring is Lacking Prior to Biologic Therapy Changes in Routine Inflammatory Bowel Disease Clinical Practice: TARGET-IBD

Weight Loss and Change in Alanine Aminotransferase (ALT) Among Patients with Nonalcoholic Fatty Liver Disease (NAFLD) Receiving Standard Care in Real World Clinical Practice: TARGET-NASH

Incidence of Achieving Weight Loss Goals in Usual Clinical Practice: Results for the TARGET-NASH Observational Cohort

Lipid testing trends in the US before and after the release of the 2013 ACC/AHA cholesterol guidelines

Real-world patterns of romiplostim treatment in adults with primary immune thrombocytopenia in the United States

Patterns and Predictors of Initiation of Intravenous Bisphosphonates Among Patients with Multiple Myeloma in the United States